fbpx
All about COVID19 - An initiative from WhiteCoats that brings together updates from top curated resources exclusively for healthcare professionals

London stocks rose in early trade on Thursday amid hopes of a potential coronavirus vaccine, as investors eyed the release of the latest US non-farm payrolls report. At 0840 BST, the FTSE 100 was up 0.7% at 6,198.43. The sentiment was underpinned by news that an experimental Covid-19 vaccine from Pfizer and BioNtech produced positive antibody results. Neil Wilson, chief ...

With a vigorous increase in vaccine trials around the globe, developing countries face a different challenge. Protestors in Africa gather around the University of the Witwatersrand in Johannesburg in South Africa on Wednesday reflecting long-running fears against the trials over testing drugs on people who do not understand the risks related to it even though the volunteers were given an ...

The recent outbreak of the disease COVID-19 has rattled the population all over the world. Studying the early transmission dynamics of the infection and evaluating the control measures being taken is an absolute necessity required for assessing the potential of transmission to occur in new areas. The first outbreak in almost all countries had a history of travel to Wuhan ...

A young patient in her 20’s diagnosed with COVID-19 had to undergo double lung transplant surgery. An Indian origin doctor led the study in Chicago. It was rather tragic news when it was reported that a young woman in her 20’s had to go through double lung transplant surgery due to the destruction of lungs by COVID. The surgery was ...

Around 5 drugs have either been approved by the government to use or are in the final stages of clinical trials.  With the scaring rise in COVID-19 cases every day, India is all in to find a solution to teat the deadly novel virus. Several states in India are reporting a new high in the number of COVID-19 cases. Currently, ...

As the need for the vaccine arises, the human race is reminded of how necessary it is to be careful. Several healthcare companies and researchers across the globe are burning the midnight oil for finding a safe and effective vaccine/treatment for deadly novel coronavirus. Meanwhile, some concerns related to a second wave have triggered a global dilemma. Some studies have ...

The National Vaccine Institute (NVI), a Thai public autonomous authority that coordinates vaccine affairs with domestic and international stakeholders cooperated with Genexine, a clinical-stage biotechnology company in South Korea, for the development of GX-19, a DNA vaccine material for COVID-19, as well as clinical trials. The memorandum of understanding which was with NVI came after Genexine secured approval from the ...

Antiviral drugs used so far for treating COVID-19 has been focusing on targeting specific viral species. For effective treatment, scientists have found cellular nanosponges to restrict virus replication. With the increasing number of COVID-19 cases every day, the hunt for treatment or vaccine is inevitable. So far the experimental studies on antiviral drugs are being used to treat a specific ...

As the world fights a battle of survival against a deadly virus, thousands of researchers have been on the path to find a vaccine. One such, Patanjali, an Ayurvedic consumer goods company, on Tuesday, launched 'Coronil and Swasari', what it claims is the Ayurvedic cure for treating COVID-19, which they said has been shown 100 percent favorable results during clinical ...

As the world scrambles to stem the pandemic, the US government top infectious disease expert has provided some hope of some vaccine being ready as early as November even as epidemiologists warn the novel coronavirus will not go away entirely and is likely to remain for the upcoming years to come. Scientists stated that the virus might become endemic like ...